Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.:

Injection of Syngeneic Murine Melanoma Cells to Determine Their Metastatic Potential in the Lungs.

J Vis Exp. 2016;(111)

Authors: Timmons JJ, Cohessy S, Wong ET

Abstract
Approximately 90% of human cancer deaths are linked to metastasis. Despite the prevalence and relative harm of metastasis, therapeutics for treatment or prevention are lacking. We report a method for the establishment of pulmonary metastases in mice, useful for the study of this phenomenon. Tail vein injection of B57BL/6J mice with B16-BL6 is among the most used models for melanoma metastases. Some of the circulating tumor cells establish themselves in the lungs of the mouse, creating "experimental" metastatic foci. With this model it is possible to measure the relative effects of therapeutic agents on the development of cancer metastasis. The difference in enumerated lung foci between treated and untreated mice indicates the efficacy of metastases neutralization. However, prior to the investigation of a therapeutic agent, it is necessary to determine an optimal number of injected B16-BL6 cells for the quantitative analysis of metastatic foci. Injection of too many cells may result in an overabundance of metastatic foci, impairing proper quantification and overwhelming the effects of anti-cancer therapies, while injection of too few cells will hinder the comparison between treated and controls.

PMID: 27285567 [PubMed - as supplied by publisher]

from Melanoma2 via ola Kala on Inoreader
via IFTTT

from #Med Blogs by Alexandros G.Sfakianakis via Alexandros G.Sfakianakis on Inoreader http://ift.tt/230i6Rz
via IFTTT